Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 26.40M $289.34M Sept. 30, 2015
PRIMECAP Management Company 19.74M $216.39M Sept. 30, 2015
First Trust Advisors 10.38M $113.82M Sept. 30, 2015
Vanguard 10.21M $111.56M Sept. 30, 2015
BlackRock Fund Advisors 9.79M $107.28M Sept. 30, 2015
HealthCor Management 9.20M $66.88M June 30, 2011
Ulys 5.17M $28.93M Dec. 31, 2011
STATE STREET CORPORATION 4.72M $51.72M Sept. 30, 2015
JPMORGAN CHASE & CO 4.55M $50.01M March 31, 2015
BVF 4.21M $44.93M Sept. 30, 2012
Inves 4.20M $46.00M Sept. 30, 2015
Millennium Management 4.04M $44.22M Sept. 30, 2015
HealthCor Management 4.00M $46.20M June 30, 2013
Federated Investors 3.58M $39.28M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 3.17M $34.78M Sept. 30, 2015

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M